YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Amgen to buy Celgene's Otezla for $13B

Posted online

Amgen Inc. agreed to buy Celgene Corp.'s psoriasis treatment called Otezla for $13.4 billion.

The deal allows Bristol-Myers Squibb Co. to move forward on its acquisition of Celgene.

Otezla's sales were $1.6 billion last year.

Read more from The Wall Street Journal.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences